摘要
Multiple sclerosis is an immune-mediated
demyelinating disease of the central nervous system with still unknown
etiology. The basis for the progressive nature of neurological disabilities
in MS is ongoing myelin destruction and a failure of remyelination. This is
resulting in a progressive axonal damage with limited remyelination.
Transcriptional analysis and observations from previous studies in murine
Theiler’s virus encephalomyelitis (TME), an experimental, virus-induced
animal model of MS lead to different underlying mechanisms. On the one hand
oligodendrocyte precursor cells (OPC) are present in the lesion but do not
differentiate into myelinating oligodendrocytes and on the other hand,
substantial, transcriptional changes are present concerning the cholesterol
biosynthesis.
Therefore, the objectives of this thesis
were first to identify the underlying mechanisms leading to the dysregulation
of OPC differentiation and second to analyze the changes in cholesterol
metabolism and study the possible influence on de- and remyelination by
dietary cholesterol supplementation.
Therefore five weeks old, female SJL/J
mice were infected intracerebrally with the low virulent BeAn strain of TME
virus. Mock-infected animals served as controls. The motoric performance of
the animals was evaluated weekly by Rotarod test over the studied period from
7-196 days post infection (dpi). At different stages of the disease 6 animals
per group was necropsied and evaluated by histology, immunohistochemistry and
oligonucleotide microarrays. In addition, the effect of activation and
inhibition of the STAT3 signalling pathway on glial precursor cells was
examined in vitro on BO-1 cells and primary rat OPC cultures for in the first
part of the study.
In the second part an additional feeding
experiment was performed to clarify the influence of hypercholesterolemia on
the disease course in TME. For this purpose one group of animals was fed a
conventional mouse diet, the other group received a high-fat and
high-cholesterol Paigen-diet throughout the complete period of the
experiment. Subsequently, the lipid composition of liver, blood and spinal
cord was assessed by high performance liquid chromatography.
In the first part of the study, a high
correlation between the immunohistochemically evaluated OPC-density and the
transcriptional change in the JAK-STAT signaling pathway was observed by
using microarray technology. Immunohistologically an increased amount of
STAT3-expressing astrocytes, OPCs and microglia / macrophages was observed in
TME infected animals. In subsequent cell culture experiment in both, BO-1
cells and primary OPC cultures, an increased expression of GFAP and a reduced
expression of CNPase was detect, after activating the STAT3 signaling pathway
by Meteorin. Inhibiting the STAT3 signaling pathway by STAT3 inhibitor VII
initiated the opposite effect in BO-1 cells.
In the second part of the present study,
a progressive, transcriptional down-regulation of genes involved in
cholesterol biosynthesis was detected. The content of galactocerebrosides and
sphingomyelins in the spinal cord was reduced in the advanced stage of TME.
The dietary cholesterol supplementation had no impact on the degree and
quality of inflammatory changes, de- and remyelination in the TME model.
Interestingly, no negative effect of serum hypercholesterolemia was
recognizable in atherosclerosis-resistant SJL/J mice. In summary, the study shows that STAT3
signaling pathway plays a key role in the regulation of OPC differentiation.
Due to the changes observed in vitro, it is likely that STAT3 promotes the
differentiation of OPCs to astrocytes and is thus leading to a persistent
astrogliosis. Moreover, serum hypercholesterolemia exhibits no negative
effect on virus-induced, inflammatory demyelination in the CNS in this
atherosclerosis-resistant mouse strain. The reported findings could indicate,
that the inconclusive reports regarding hypercholesterolemia and MS maybe
influenced by rather indirect pathomechanistic factors or the confounding
influence of the respective genetic predisposition towards atherosclerosis.